Literature DB >> 9504775

Growth hormone receptor expression in the nucleus and cytoplasm of normal and neoplastic cells.

D T Lincoln1, F Sinowatz, L Temmim-Baker, H I Baker, S Kölle, M J Waters.   

Abstract

Growth hormone (GH) exerts its regulatory functions in controlling metabolism, balanced growth and differentiated cell expression by acting on specific receptors which trigger a phosphorylation cascade, resulting in the modulation of numerous signalling pathways dictating gene expression. A panel of five monoclonal antibodies was used in mapping the presence and somatic distribution of the GH receptor by immunohistochemistry in normal and neoplastic tissues and cultured cells of human, rat and rabbit origin. A wide distribution of the receptor was observed in many cell types. Not all cells expressing cytoplasmic GH receptors displayed nuclear immunoreactivity. In general, the relative proportion of positive cells and intensity of staining was higher in neoplastic cells than in normal tissue cells. Immunoreactivity showed subcellular localisation of the GH receptor in cell membranes and was predominantly cytoplasmic, but strong nuclear immunoreaction was also apparent in many instances. Intense immunoreactivity was also observed in the cellular Golgi area of established cell lines and cultured tissue-derived cells in exponential growth phase, indicating cells are capable of GH receptor synthesis. The presence of intracellular GH receptor, previously documented in normal tissues of mostly animal origin, is the result of endoplasmic reticulum and Golgi localisation. Heterogeneity of immunoreactivity was found in normal and neoplastic tissue with a variable range of positive cells. The nuclear localisation of immunoreactivity is the result of nuclear GH receptor/binding protein, identically to the cytosolic and plasma GH-binding protein, using a panel of five monoclonal antibodies against the GH receptor extracellular region. The expression of GH receptors, not only on small proliferating tumour cells such as lymphocytes, but also on well differentiated cells including keratinocytes, suggests that GH is necessary not only for differentiation of progenitor cells, but also for their subsequent clonal expansion, differentiation and maintenance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9504775     DOI: 10.1007/s004180050212

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  14 in total

1.  HMGN2 inducibly binds a novel transactivation domain in nuclear PRLr to coordinate Stat5a-mediated transcription.

Authors:  Alyson A Fiorillo; Terry R Medler; Yvonne B Feeney; Yi Liu; Kalie L Tommerdahl; Charles V Clevenger
Journal:  Mol Endocrinol       Date:  2011-08-04

2.  Growth hormone receptor is expressed in human breast cancer.

Authors:  M Gebre-Medhin; L G Kindblom; H Wennbo; J Törnell; J M Meis-Kindblom
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

3.  Validation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature Pigs.

Authors:  Jennifer Mitchell; Peggy T Tinkey; Rony Avritscher; Carolyn Van Pelt; Ghazaleh Eskandari; Suraj Konnath George; Lianchun Xiao; Erik Cressman; Jeffrey S Morris; Asif Rashid; Ahmed O Kaseb; Hesham M Amin; Rajesh Uthamanthil
Journal:  Oncology       Date:  2016-06-16       Impact factor: 2.935

4.  Growth hormone receptor expression in human colorectal cancer.

Authors:  Xiaodong Yang; Fukun Liu; Zhe Xu; Che Chen; Gang Li; Xiaoyu Wu; Jieshou Li
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

5.  Identification of growth hormone receptor in localised neurofibromas of patients with neurofibromatosis type 1.

Authors:  K S G Cunha; E P Barboza; E C Da Fonseca
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

6.  Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.

Authors:  Vijay Pandey; Jo K Perry; Kumarasamypet M Mohankumar; Xiang-Jun Kong; Shu-Min Liu; Zheng-Sheng Wu; Murray D Mitchell; Tao Zhu; Peter E Lobie
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

7.  The prolactin receptor transactivation domain is associated with steroid hormone receptor expression and malignant progression of breast cancer.

Authors:  Alyson A Fiorillo; Terry R Medler; Yvonne B Feeney; Suzanne M Wetz; Kalie L Tommerdahl; Charles V Clevenger
Journal:  Am J Pathol       Date:  2012-11-14       Impact factor: 4.307

8.  Exercise training effects on skeletal muscle plasticity and IGF-1 receptors in frail elders.

Authors:  Maria L Urso; Maria A Fiatarone Singh; Wenjing Ding; William J Evans; Arthur C Cosmas; Thomas G Manfredi
Journal:  Age (Dordr)       Date:  2005-12-10

9.  Small chicken growth hormone (scGH) variant in the neural retina.

Authors:  Marie-Laure Baudet; Steve Harvey
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

Review 10.  Minireview: mechanisms of growth hormone-mediated gene regulation.

Authors:  Dennis J Chia
Journal:  Mol Endocrinol       Date:  2014-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.